Skip to content

Aromatherapy Massage for Itching Management in Liver Diseases

The Effect of Aromatherapy Massage on Itching, Comfort, Skin pH Level, and Skin Moisture in Liver Diseases: Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05367414
Enrollment
36
Registered
2022-05-10
Start date
2020-02-13
Completion date
2021-06-23
Last updated
2025-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aromatherapy, Itching, Liver Diseases, Massage, pH Level, Skin Moisture

Keywords

aromatherapy, massage, liver Diseases, itching

Brief summary

The aim of this study is to determine the effect of aromatherapy massage on itching, comfort, skin pH level and skin moisture in individuals with liver disease. Research Hypotheses: H1: Aromatherapy massage has an effect on the level of itching in individuals with itchy liver disease. H2: Aromatherapy massage has an effect on the general comfort level in individuals with itchy liver disease, H3: Aromatherapy massage has an effect on skin pH level in individuals with itchy liver disease. H4: Aromatherapy massage has an effect on skin moisture in individuals with itchy liver disease.

Detailed description

This randomised controlled trial was conducted in order to examine study effect of aromatherapy massage on itching, comfort, skin pH level, and skin moisture among individuals with liver diseases

Interventions

OTHERaromatherapy massage (diluted tea tree oil)

massage with diluted tea tree oil was applied

OTHERaromatherapy massage (sweet almond oil)

massage with sweet almond oil was applied

Sponsors

Amine Terzi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
37 Years to 88 Years
Healthy volunteers
No

Inclusion criteria

* patients who volunteered to participate in the study, * with a diagnosis of chronic liver disease (liver cirrhosis (primary biliary cirrhosis, alcoholic, cardiac, post-necrotic, cryptogenic cirrhosis, Wilson's Cirrhosis, hemochromatosis), chronic viral hepatitis), * had no cognitive impairment, * were not included in the pre-application, * could answer questions, * itch score of above 3 (with Visual Analogue Scale).

Exclusion criteria

* patients are taking antipruritic treatment, * have itchy skin disease before, ulcer, eczema, etc. in the area to be applied * patients with dermatological problems, any swelling or signs of inflammation in the area ---to be treated, neuropathy or loss of sensation in the area to be treated * patients with allergic to tea tree oil, perfume, or cosmetics, * diagnosed with cancer

Design outcomes

Primary

MeasureTime frameDescription
ItchingDay 1Itching was assessed with the 5D Itch Scale. The total score of the scale ranges from 5 to 25, with 5 points indicating the absence of itching and 25 points indicating the highest severity of itching.
comfortDay 1Comfort assessed with the General Comfort Scale. The score to be obtained from the scale varies between 48 and 192. 48 points indicating the low comfort level and 192 points indicating the high comfort level.
skin pH levelDay 1For pH level measurement, the F-74 G model skin pH measuring device manufactured by HORIBA Scientific and ISFET (Ion Sensitive Field Effect Transistor) 0040-10D model pH electrode produced by HORIBA Scientific were used.
skin moisture levelDay 1DMM brand skin moisture measuring device was used to measure skin moisture level.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026